Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Gary J. Young, Md Mahmudul Hasan, Leonard D. Young & Md. Noor-E-Alam. (2023) Treatment Experiences for Patients Receiving Buprenorphine/Naloxone for Opioid Use Disorder: A Qualitative Study of Patients’ Perceptions and Attitudes. Substance Use & Misuse 58:4, pages 512-519.
Read now
Read now
Mikkel H. Pedersen, Anne Danø, Carl Gibbons & Rasmus Jensen. (2022) Administration and patient-incurred costs associated with opioid agonist treatment in Norway. Current Medical Research and Opinion 38:11, pages 1959-1965.
Read now
Read now
Md Mahmudul Hasan, Md. Noor-E-Alam, Jiesheng Shi, Leonard D. Young & Gary J. Young. (2022) Long-term patient outcomes following buprenorphine/naloxone treatment for opioid use disorder: a retrospective analysis in a commercially insured population. The American Journal of Drug and Alcohol Abuse 48:4, pages 481-491.
Read now
Read now
Wendy P. Guastaferro, Deborah Koetzle, Laura Lutgen-Nieves & Brent Teasdale. (2022) Opioid Agonist Treatment Recipients within Criminal Justice-Involved Populations. Substance Use & Misuse 57:5, pages 698-707.
Read now
Read now
Maykel Farag Ghabrash, Arash Bahremand, Martine Veilleux, Geneviève Blais-Normandin, Gabrielle Chicoine, Catherine Sutra-Cole, Navdeep Kaur, Daniela Ziegler, Simon Dubreucq, Louis-Christophe Juteau, Laurent Lestage & Didier Jutras-Aswad. (2020) Depression and Outcomes of Methadone and Buprenorphine Treatment Among People with Opioid Use Disorders: A Literature Review. Journal of Dual Diagnosis 16:2, pages 191-207.
Read now
Read now
Naoko A Ronquest, Tina M Willson, Leslie B Montejano, Vijay R Nadipelli & Bernd A Wollschlaeger. (2018) Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder. Substance Abuse and Rehabilitation 9, pages 59-78.
Read now
Read now
Elizabeth T. Masters, Arvind Ramaprasan, Jack Mardekian, Roy E. Palmer, David E. Gross, David Cronkite, Michael Von Korff & David S. Carrell. (2018) Natural Language Processing–Identified Problem Opioid Use and Its Associated Health Care Costs. Journal of Pain & Palliative Care Pharmacotherapy 32:2-3, pages 106-115.
Read now
Read now
Ankit Shah, Margaret Duncan, Nipun Atreja, Kei Sing Tai & Mugdha Gore. (2018) Healthcare utilization and costs associated with treatment for opioid dependence. Journal of Medical Economics 21:4, pages 406-415.
Read now
Read now
Ty S. Schepis & Jahn K. Hakes. (2017) Age of initiation, psychopathology, and other substance use are associated with time to use disorder diagnosis in persons using opioids nonmedically. Substance Abuse 38:4, pages 407-413.
Read now
Read now
John A. Carter, Ryan Dammerman & Michael Frost. (2017) Cost-effectiveness of subdermal implantable buprenorphine versus sublingual buprenorphine to treat opioid use disorder. Journal of Medical Economics 20:8, pages 893-901.
Read now
Read now
Raj K. Kalapatapu, Tatiana P. Dannenbaum, John D. Harbison & Beth E. Cohen. (2017) Does trauma exposure predict prescription drug problems beyond the contribution of post-traumatic stress disorder and depression? An analysis of the Mind Your Heart cohort study. Journal of Addictive Diseases 36:3, pages 183-192.
Read now
Read now
Carl L. Roland, Joanita Lake & Gary M. Oderda. (2016) Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic Review. Journal of Pain & Palliative Care Pharmacotherapy 30:4, pages 258-268.
Read now
Read now
Articles from other publishers (51)
Sarah Cercone Heavey, Gregory P. Beehler & Jennifer Funderburk. (2024) (RE-)AIMing for Rapid Uptake. Medical Care 62:1, pages 44-51.
Crossref
Crossref
Jing Jia & Zhongtian Li. (2024) Opioid abuse and labor investment efficiency. International Review of Economics & Finance 89, pages 1267-1285.
Crossref
Crossref
Alina Cernasev, Kenneth Hohmeier, Craig Field, Adam J. Gordon, Stacy Elliott, Kristi Carlston, Grace Broussard & Gerald Cochran. (2023) Co-use of Opioid Medications and Alcohol Prevention Study (COAPS). Substance Abuse.
Crossref
Crossref
Tomasz Zaprutko, Dorota Kopciuch, Anna Paczkowska, Józefina Sprawka, Julia Cynar, Monika Pogodzińska, Katarzyna Niewczas, Aleksandra Stolecka, Maria Sygit, Michał Michalak, Piotr Ratajczak & Krzysztof Kus. (2022) Facebook as a source of access to medicines. PLOS ONE 17:10, pages e0275272.
Crossref
Crossref
David R. Gilley, Andrew D. Clark, Maggie E. Wieser, Craig A. Bollig, Laura M. Dooley & Gregory B. Biedermann. (2022) Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution. Head & Neck 44:6, pages 1368-1376.
Crossref
Crossref
Kathy Xu, Seonaid Nolan, Tamara Mihic & Lianping Ti. (2022) Improving opioid stewardship programs through shared decision-making. Journal of the American Pharmacists Association 62:3, pages 697-700.
Crossref
Crossref
Antoinette R. Esce & Duncan A. Meiklejohn. (2022) Ibuprofen prescription following adult tonsillectomy reduces postoperative opioid use. American Journal of Otolaryngology 43:3, pages 103436.
Crossref
Crossref
Tyler Marshall, Myles Hancock, Elizabeth N. Kinnard, Karin Olson, Adam Abba-Aji, Katherine Rittenbach, Jonathan N. Stea, Robert Tanguay & Sunita Vohra. (2022) Treatment options and shared decision-making in the treatment of opioid use disorder: A scoping review. Journal of Substance Abuse Treatment 135, pages 108646.
Crossref
Crossref
Yasna Rostam-Abadi, Jaleh Gholami, Alireza Noroozi, Mina Ansari, Shahab Baheshmat, Marziyeh Hamzehzadeh, Mohammad Reza Ghadirzadeh, Bita Vahdani, Hamed Ekhtiari, Ramin Mojtabai & Afarin Rahimi-Movaghar. (2022) Public health risks associated with methadone in Iran: A systematic review and meta-analysis. International Journal of Drug Policy 100, pages 103529.
Crossref
Crossref
Parissa J. Ballard, Melinda Pankratz, Kimberly G. Wagoner, Jennifer Cornacchione Ross, Scott D. Rhodes, Sunday Azagba, Eunyoung Y. Song & Mark Wolfson. (2021) Changing course: supporting a shift to environmental strategies in a state prevention system. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Crossref
Md Mahmudul Hasan, Gary J. Young, Jiesheng Shi, Prathamesh Mohite, Leonard D. Young, Scott G. Weiner & Md. Noor-E-Alam. (2021) A machine learning based two-stage clinical decision support system for predicting patients’ discontinuation from opioid use disorder treatment: retrospective observational study. BMC Medical Informatics and Decision Making 21:1.
Crossref
Crossref
Md Mahmudul Hasan, Md. Noor-E-Alam, Prathamesh Mohite, Md Saiful Islam, Alicia Sasser Modestino, Alyssa M. Peckham, Leonard D. Young & Gary J. Young. (2021) Patterns of patient discontinuation from buprenorphine/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts. Journal of Substance Abuse Treatment 131, pages 108416.
Crossref
Crossref
Nikhil Jain, Mayur Sharma, Dengzhi Wang, Beatrice Ugiliweneza, Doniel Drazin & Maxwell Boakye. (2021) Burden of preoperative opioid use and its impact on healthcare utilization after primary single level lumbar discectomy. The Spine Journal 21:10, pages 1700-1710.
Crossref
Crossref
David R Bright, Natasha Petry, Eric Roath & Tyler Gibb. (2021) Engaging pharmacogenomics in pain management and opioid selection. Pharmacogenomics 22:14, pages 927-937.
Crossref
Crossref
Gabriel Bastien, Claudio Del Grande, Alina Dyachenko, Janusz Kaczorowski, M. Gabrielle Pagé, Suzanne Brissette, François Lespérance, Simon Dubreucq, Peter Hooley & Didier Jutras-Aswad. (2021) Preferences for research design and treatment of comorbid depression among patients with an opioid use disorder: A cross-sectional discrete choice experiment. Drug and Alcohol Dependence 226, pages 108857.
Crossref
Crossref
Jing Xu, Nazik M. A. Zakari, Hanadi Y. Hamadi, Sinyoung Park, Donald Rob Haley & Mei Zhao. (2021) The Financial Burden of Opioid-Related Abuse among Surgical and Non-Surgical Patients in Florida: A Longitudinal Study. International Journal of Environmental Research and Public Health 18:17, pages 9127.
Crossref
Crossref
Benjamin A. HowellRosemarie A. MartinRebecca LebeauAshley Q. TruongEmily A. WangJosiah D. RichJennifer G. Clarke. (2021) Changes In Health Services Use After Receipt Of Medications For Opioid Use Disorder In A Statewide Correctional System. Health Affairs 40:8, pages 1304-1311.
Crossref
Crossref
STEVEN Z. GEORGE, TREVOR A. LENTZ & CHRISTINE M. GOERTZ. (2021) Back and neck pain: in support of routine delivery of non-pharmacologic treatments as a way to improve individual and population health. Translational Research 234, pages 129-140.
Crossref
Crossref
Chad M BrummettJackie Evans-ShieldsChristina EnglandAmanda M KongCarolyn R LewCaroline HenriquesNicole M ZimmermanEric C Sun. (2021) Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients. Journal of Managed Care & Specialty Pharmacy 27:6, pages 760-771.
Crossref
Crossref
John S. Magel, Adam J. Gordon, Julie M. Fritz & Jaewhan Kim. (2021) The Influence of an Opioid Use Disorder on Initiating Physical Therapy for Low Back Pain: A Retrospective Cohort. Journal of Addiction Medicine 15:3, pages 226-232.
Crossref
Crossref
Chukwuweike U. Gwam, Ahmed K. Emara, Ivuoma A. Ogbonnaya, Andrey Zuskov, T. David Luo & Johannes F. Plate. (2021) Addressing National Opioid Prescribing Practices for Knee Osteoarthritis: An Analysis of an Estimated 41,389,332 Patients With Knee Arthritis. Journal of the American Academy of Orthopaedic Surgeons 29:7, pages e337-e344.
Crossref
Crossref
Samantha Anne, James “Whit” Mims, David E. Tunkel, Richard M. Rosenfeld, David S. Boisoneau, Michael J. Brenner, John D. Cramer, David Dickerson, Sandra A. Finestone, Adam J. Folbe, Deepa J. Galaiya, Anna H. Messner, Allison Paisley, Ahmad R. Sedaghat, Kerstin M. Stenson, Angela K. Sturm, Erin M. Lambie, Nui Dhepyasuwan & Taskin M. Monjur. (2021) Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations Executive Summary. Otolaryngology–Head and Neck Surgery 164:4, pages 687-703.
Crossref
Crossref
Samantha Anne, James “Whit” Mims, David E. Tunkel, Richard M. Rosenfeld, David S. Boisoneau, Michael J. Brenner, John D. Cramer, David Dickerson, Sandra A. Finestone, Adam J. Folbe, Deepa J. Galaiya, Anna H. Messner, Allison Paisley, Ahmad R. Sedaghat, Kerstin M. Stenson, Angela K. Sturm, Erin M. Lambie, Nui Dhepyasuwan & Taskin M. Monjur. (2021) Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations. Otolaryngology–Head and Neck Surgery 164:S2.
Crossref
Crossref
Craig A. Bollig, Brian P. Kinealy, David R. Gilley, Andrew D. Clark, Tabitha L.I. Galloway, Robert P. Zitsch, Jeffrey B. Jorgensen & Gregory B. Biedermann. (2020) Implications of Treatment Modality on Chronic Opioid Use Following Treatment for Head and Neck Cancer. Otolaryngology–Head and Neck Surgery 164:4, pages 799-806.
Crossref
Crossref
Nikhil Jain, Frank M. Phillips, Azeem T. Malik & Safdar N. Khan. (2021) Preoperative Opioid Weaning Before Major Spinal Fusion. Spine 46:2, pages 80-86.
Crossref
Crossref
Aziza Arifkhanova, Emily McCormick Kraus, Alia Al-Tayyib, Julie Taub, Annette Encinias, Dean McEwen, Arthur Davidson & Judith C. Shlay. (2021) Estimating costs of hospitalizations associated with opioid use disorder or opioid misuse at a large, urban safety-net hospital—Denver, Colorado, 2017. Drug and Alcohol Dependence 218, pages 108306.
Crossref
Crossref
Sean M. Murphy. (2020) The cost of opioid use disorder and the value of aversion. Drug and Alcohol Dependence 217, pages 108382.
Crossref
Crossref
Jenny W. Sun, Jessica M. Franklin, Kathryn Rough, Rishi J. Desai, Sonia Hernández-Díaz, Krista F. Huybrechts & Brian T. Bateman. (2020) Predicting overdose among individuals prescribed opioids using routinely collected healthcare utilization data. PLOS ONE 15:10, pages e0241083.
Crossref
Crossref
Brandon K. Nguyen, James Stathakios, Daniel Quan, Jessica Pinto, Hosheng Lin, Anna A. Pashkova & Peter F. Svider. (2020) Perioperative Analgesia for Patients Undergoing Thyroidectomy and Parathyroidectomy: An Evidence-Based Review. Annals of Otology, Rhinology & Laryngology 129:10, pages 949-963.
Crossref
Crossref
Abay Asfaw, Brian Quay & Chia-Chia Chang. (2020) Do Injured Workers Receive Opioid Prescriptions Outside the Workers’ Compensation System?. Journal of Occupational & Environmental Medicine 62:9, pages e515-e522.
Crossref
Crossref
Sherif H. Hassanien, Jonathon R. Bassman, Carmelita M. Perrien Naccarato, Jack J. Twarozynski, John R. Traynor, Donna M. Iula & Jessica P. Anand. (2020)
In vitro
pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis
. Drug Testing and Analysis 12:8, pages 1212-1221.
Crossref
Crossref
J. Logan BrockNikhil JainFrank M. PhillipsAzeem T. MalikSafdar N. Khan. (2019) Postoperative opioid cessation rates based on preoperative opioid use. The Bone & Joint Journal 101-B:12, pages 1570-1577.
Crossref
Crossref
Shuyan Wei, Charles Green, Van Thi Thanh Truong, John Howell, Stephanie Martinez Ugarte, Rondel Albarado, Ethan A. Taub, David E. Meyer, Sasha D. Adams, Michelle K. McNutt, Laura J. Moore, Bryan A. Cotton, Lillian S. Kao, Charles E. Wade, John B. Holcomb & John A. Harvin. (2019) Implementation of a multi-modal pain regimen to decrease inpatient opioid exposure after injury. The American Journal of Surgery 218:6, pages 1122-1127.
Crossref
Crossref
Winston E. Abara, Jaeyoung Hong, Tandin Dorji, Michele K. Bohm, Emily J. Weston, Kyle T. Bernstein & Robert D. Kirkcaldy. (2019) Association between trends in county-level opioid prescribing and reported rates of gonorrhea cases in the United States. Annals of Epidemiology 36, pages 26-32.
Crossref
Crossref
Ty S. Schepis, Timothy E. Wilens & Sean Esteban McCabe. (2019) Prescription Drug Misuse: Sources of Controlled Medications in Adolescents. Journal of the American Academy of Child & Adolescent Psychiatry 58:7, pages 670-680.e4.
Crossref
Crossref
Craig A. Bollig & Jeffrey B. Jorgensen. (2019) Effect of treatment modality on chronic opioid use in patients with T1/T2 oropharyngeal cancer. Head & Neck 41:4, pages 892-898.
Crossref
Crossref
Nikhil Jain, John L. Brock, Azeem Tariq Malik, Frank M. Phillips & Safdar N. Khan. (2019) Prediction of Complications, Readmission, and Revision Surgery Based on Duration of Preoperative Opioid Use. Journal of Bone and Joint Surgery 101:5, pages 384-391.
Crossref
Crossref
Brent A. Metfessel, Michelle D. Mentel, Amy Phanel, Mary Ann Dimartino, Mureen Allen & Samuel Ho. (2018) Opioid Use is Associated with Higher Severity-Adjusted Episode Costs in Patients with Conservatively Managed Degenerative Joint Disease of the Back and Neck. PharmacoEconomics 37:3, pages 419-433.
Crossref
Crossref
Mayur Sharma, Beatrice Ugiliweneza, Pooja Sirdeshpande, Dengzhi Wang & Maxwell Boakye. (2019) Opioid Dependence and Health Care Utilization After Decompression and Fusion in Patients With Adult Degenerative Scoliosis. Spine 44:4, pages 280-290.
Crossref
Crossref
Carl L. RolandXiangyang YeVanessa StevensGary M. Oderda. (2019) The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning. Journal of Managed Care & Specialty Pharmacy 25:1, pages 18-27.
Crossref
Crossref
Kathleen A. Fairman, Alyssa M. Peckham, Michael L. Rucker, Jonah H. Rucker & David A. Sclar. (2018) Use of power-law analysis to predict abuse or diversion of prescribed medications: proof-of-concept mathematical exploration. BMC Research Notes 11:1.
Crossref
Crossref
Nikhil Jain, John L. Brock, Frank M. Phillips, Tristan Weaver & Safdar N. Khan. (2018) Chronic preoperative opioid use is a risk factor for increased complications, resource use, and costs after cervical fusion. The Spine Journal 18:11, pages 1989-1998.
Crossref
Crossref
Marcia Reinhart, Lauren M. Scarpati, Noam Y. Kirson, Cody Patton, Nina Shak & Jennifer G. Erensen. (2018) The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017. Applied Health Economics and Health Policy 16:5, pages 609-632.
Crossref
Crossref
Ahmed N. Hassan & Edward Nunes. (2018) Medication Treatments for Opioid Use Disorder: What Is the Impact on Mood and Mood Disorders?. Current Addiction Reports 5:3, pages 303-311.
Crossref
Crossref
Mayur Sharma, Beatrice Ugiliweneza, Zaid Aljuboori & Maxwell Boakye. (2018) Health care utilization and overall costs based on opioid dependence in patients undergoing surgery for degenerative spondylolisthesis. Neurosurgical Focus 44:5, pages E14.
Crossref
Crossref
Grisell Vargas-Schaffer & Jennifer Cogan. (2018) Attitudes Toward Opioids and Risk of Misuse/Abuse in Patients with Chronic Noncancer Pain Receiving Long-term Opioid Therapy. Pain Medicine 19:2, pages 319-327.
Crossref
Crossref
Gregory L Stuart, Ryan C Shorey, Christopher R France, Jenny Macfie, Kathryn Bell, Kimberly B Fortner, Craig V Towers, Paul Schkolnik & Susan Ramsey. (2018) Empirical Studies Addressing the Opioid Epidemic: An Urgent Call for Research. Substance Abuse: Research and Treatment 12, pages 117822181878429.
Crossref
Crossref
Asad Jehangir & Henry P Parkman. (2017) Chronic opioids in gastroparesis: Relationship with gastrointestinal symptoms, healthcare utilization and employment. World Journal of Gastroenterology 23:40, pages 7310-7320.
Crossref
Crossref
Tulio Eduardo Nogueira, Patrícia Azevedo Lino, Maria Auxiliadora Parreiras Martins, Maria Elisa Souza Silva, Claudio Rodrigues Leles & Mauro Henrique Nogueira Guimarães Abreu. (2017) The economic burden of opioid prescription by dentists: A 12-month survey of consumer expenditure in Brazil. Journal of Public Health Dentistry 77:4, pages 285-289.
Crossref
Crossref
Yu-Ping Chang & Peggy Compton. (2016) Opioid Misuse/Abuse and Quality Persistent Pain Management in Older Adults. Journal of Gerontological Nursing 42:12, pages 21-30.
Crossref
Crossref
Stephen S. Johnston, Andrea H. Alexander, Elizabeth T. Masters, Jack Mardekian, David Semel, Elisabetta Malangone-Monaco, Ellen Riehle, Kathleen Wilson & Alesia Sadosky. (2016) Costs and Work Loss Burden of Diagnosed Opioid Abuse Among Employees on Workers Compensation or Short-term Disability. Journal of Occupational & Environmental Medicine 58:11, pages 1087-1097.
Crossref
Crossref